OKYO Pharma Ltd (NASDAQ:OKYO) told investors it has closed its previously announced best efforts registered direct offering of shares.
The company issued 2,666,670 ordinary shares at $1.50 each to individuals and institutions, raising gross proceeds of $4 million.
It said it intends to use the net proceeds from the offering primarily for clinical development of its product candidates, general corporate purposes and working capital.